Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2026-01-03 @ 8:35 AM
Study NCT ID:
NCT00813059
Status:
UNKNOWN
Last Update Posted:
2012-02-08
First Post:
2008-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
Sponsor:
Mount Sinai Hospital, Canada
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
edmargolin
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None